Status
ACTIVE
Global HQ
New York, United States
Countries of investment
- USA
- United Kingdom
- Japan
- Israel
- Canada
- Mexico
- Brazil
- France
- Germany
- China
Investment stages
- Pre-Seed
- Seed
Industries
- Fintech
- AI
- Health Tech
- Blockchain
- Web3
About
Petri Petri is a pioneering biotech company dedicated to fostering innovation at the intersection of biology and engineering by providing essential pre-seed capital, strategic support, and valuable connections to early-stage startups. Co-founded by a team of seasoned leaders and academics, Petri is committed to nurturing the next generation of groundbreaking technologies and solutions that address critical challenges in healthcare and beyond. With a focus on collaboration and mentorship, Petri empowers visionary entrepreneurs to accelerate their ideas into impactful ventures, ultimately shaping the future of biotechnology. Through its robust network and expertise, Petri aims to be a catalyst for transformative advancements in the life sciences sector.
Petri Petri is a pioneering biotech company dedicated to fostering innovation at the intersection of biology and engineering by providing essential pre-seed capital, strategic support, and valuable connections to early-stage startups. Co-founded by a team of seasoned leaders and academics, Petri is committed to nurturing the next generation of groundbreaking technologies and solutions that address critical challenges in healthcare and beyond. With a focus on collaboration and mentorship, Petri empowers visionary entrepreneurs to accelerate their ideas into impactful ventures, ultimately shaping the future of biotechnology. Through its robust network and expertise, Petri aims to be a catalyst for transformative advancements in the life sciences sector.
Investment Thesis
They invest in startups at the intersection of biology and tech, applied to planetary and human health.
Manager's Experience
Backed by extensive expertise in the biotechnology sector, the fund manager has successfully executed over 30 investments across North America and Europe. With a thematic approach focused on transformative healthcare solutions, they emphasize early-stage opportunities that promise significant innovation. Their track record includes notable exits that demonstrate a keen ability to identify and nurture high-potential ventures. This operator-first strategy ensures that portfolio companies receive not only financial support but also strategic guidance to drive sustainable growth.
Team
Tony Kulesa
Jamie Goldstein